Eli Lilly and Co. (NYSE:LLY) fell 0.9% during trading on Friday . The stock traded as low as $76.49 and last traded at $76.54, with a volume of 1,906,320 shares traded. The stock had previously closed at $77.23.

Several research firms recently commented on LLY. Leerink Swann reiterated a “buy” rating on shares of Eli Lilly and in a report on Sunday, June 26th. Morgan Stanley reiterated a “hold” rating and issued a $88.00 price objective on shares of Eli Lilly and in a report on Saturday, June 4th. Jefferies Group restated a “buy” rating and set a $100.00 price target on shares of Eli Lilly and in a research note on Friday, May 13th. BMO Capital Markets restated a “buy” rating and set a $94.00 price target on shares of Eli Lilly and in a research note on Wednesday, July 27th. Finally, Zacks Investment Research upgraded Eli Lilly and from a “hold” rating to a “buy” rating and set a $93.00 price target for the company in a research note on Friday, July 29th. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. Eli Lilly and has an average rating of “Buy” and a consensus price target of $96.58.

The stock has a market cap of $81.28 billion and a price-to-earnings ratio of 33.12. The stock has a 50 day moving average of $80.39 and a 200 day moving average of $76.26.

Eli Lilly and (NYSE:LLY) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $0.86 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.86. The firm earned $5.40 billion during the quarter, compared to analyst estimates of $5.14 billion. During the same period in the prior year, the company posted $0.90 earnings per share. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. Equities analysts predict that Eli Lilly and Co. will post $3.59 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 9th. Investors of record on Monday, August 15th will be issued a dividend of $0.51 per share. This represents a $2.04 annualized dividend and a yield of 2.65%. The ex-dividend date of this dividend is Thursday, August 11th.

In related news, SVP Melissa S. Barnes sold 992 shares of the firm’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $73.77, for a total transaction of $73,179.84. Following the sale, the senior vice president now directly owns 10,710 shares of the company’s stock, valued at $790,076.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Jackson P. Tai bought 5,773 shares of the company’s stock in a transaction that occurred on Monday, August 15th. The shares were bought at an average cost of $80.43 per share, for a total transaction of $464,322.39. Following the completion of the acquisition, the director now owns 42,306 shares of the company’s stock, valued at $3,402,671.58. The disclosure for this purchase can be found here.

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company’s human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.